Investigating how certain cell signaling affects insulin secretion in diabetes
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetes
This study is looking at how certain signals in the pancreas affect insulin and somatostatin release, which is important for people with type-2 diabetes, to help find new ways to better manage blood sugar levels.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11123304 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms that regulate insulin and somatostatin secretion in the pancreas, particularly in patients with type-2 diabetes. It examines how specific receptors in the islet cells influence calcium handling and insulin release, which are critical for maintaining blood sugar levels. By studying both human and animal models, the research aims to uncover how disruptions in these signaling pathways contribute to diabetes. The findings could lead to new therapeutic strategies to improve glucose regulation in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type-2 diabetes who experience difficulties in blood glucose regulation.
Not a fit: Patients without diabetes or those with other forms of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for managing blood sugar levels in patients with type-2 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding similar signaling pathways in diabetes, suggesting that this approach could yield valuable insights.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Jacobson, David Aaron — Vanderbilt University
- Study coordinator: Jacobson, David Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.